Trius Therapeutics Gains Membership in the Russell 2000(R) Index
28 juin 2011 08h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, June 28, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics...
Trius Therapeutics Announces Pricing of $30 Million Financing
25 mai 2011 09h00 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, May 25, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics...
Trius to Present at JMP Securities Research Conference
10 mai 2011 16h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, May 10, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide...
Trius Therapeutics Reports 2011 First Quarter Financial Results
05 mai 2011 16h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, May 5, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for...
Trius Antibiotic Torezolid to be Highlighted at ECCMID Meeting
04 mai 2011 16h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, May 4, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), announced today that the results of two studies of torezolid phosphate (TR-701) will be presented at the upcoming...
Trius Therapeutics Awarded Third Government Contract to Develop Novel Antibiotics
15 avr. 2011 08h30 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, April 15, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced it has been awarded a research contract by Lawrence Livermore National Laboratory (LLNL), part of...
Trius to Present at Future Leaders in the Biotech Industry
13 avr. 2011 16h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will...
Trius Announces Patent Term Extension for Torezolid Phosphate
11 avr. 2011 16h01 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, April 11, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that the Company has received official notification from the U.S. Patent and Trademark Office that...
Trius Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
23 mars 2011 16h00 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, March 23, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics...
Trius Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2010 Financial Results
17 mars 2011 16h00 HE
|
Trius Therapeutics, Inc.
SAN DIEGO, March 17, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced it expects to report fourth quarter and full year 2010 financial results after the NASDAQ Global...